Learn About Peripheral T-Cell Lymphoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Stanford Health Care
Ranjana Advani is an Oncologist and a Hematologist in Stanford, California. Dr. Advani has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Classical Hodgkin Lymphoma, and Bone Marrow Transplant.
Stanford Health Care
Robert Negrin is a Hematologist and a Hematologist Oncology provider in Stanford, California. Dr. Negrin has been practicing medicine for over 41 years and is rated as an Advanced provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant.
Lymphoma Program
Youn Kim is a Dermatologist in Palo Alto, California. Dr. Kim and is rated as an Advanced provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome.
Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause.
Summary: To learn if the study drug golidocitinib given alone or in combination with the standard drug combination therapy called CHOP can help to control PTCL.